Science News from EPI|Lifestyle 2024

Welcome to Chicago!

This is where you'll find video interviews on some of the hottest and most-talked about presentations during EPI/Lifestyle 2024.

EPI|Lifestyle 2024 Highlights

Program Committee Co-chairs Alvaro Alonso, MD, PhD, FAHA and Monica Serra, PhD welcome attendees to EPI|Lifestyle 2024 and share some of the highlights they have planned for the meeting this year.

2024 Keynote Lecturers: What's Money Got To Do With It

Program Committee Co-chair Alvaro Alonso, MD, PhD, FAHA interviews the three keynote speakers, Karen E. Joynt Maddox, MD, MPH, Alice H. Lichtenstein, DSc, and Dhruv S. Kazi, MD, MSci, MS, who presented in an opening session on the impact of money in health care outcomes.

Time-Restricted Eating and Mortality

Program Committee Co-chair Monica Serra, PhD interviews Victor Zhong, PhD about his poster, "Association Between Time-Restricted Eating and All-Cause and Cause-Specific Mortality," which he presented during a session on  Diabetes during EPI|Lifestyle 2024 in Chicago.

AHA News Release: 8-hour time-restricted eating linked to a 91% higher risk of cardiovascular death


Sugar-Sweetened Beverage Consumption through Childhood and Glycemic Outcomes

Maya Vadiveloo, PhD, RD interviews Soren Harnois-Leblanc, PhD about the latest findings from Project Viva looking at the impact of the consumption of sugar-sweetened beverages throughout childhood and adolescence on glycemic outcomes.

AHA News Release: Sugary drinks, fruit juices linked to higher risk of developing Type 2 diabetes among boys

AHA News Video: (Animated Study Results)

AHA Statements on Population Science

Elizabeth Selvin, PhD, MPH engages in insightful interviews with authors of several recently published American Heart Association statements related to #EPI|Lifestyle 2024. Seth Martin, MD, MHS, Alka Kanaya, MD, Kiarri Kershaw, PhD, MPH, and Kevin Volpp, MD, PhD, briefly describe the focus of their papers and their valuable experiences as members of AHA writing groups.

2024 American Heart Association Heart Disease and Stroke Statistics Update
Circulation, Jan. 24, 2024

Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association
Circulation, May 8, 2023

Neighborhoods and Cardiovascular Health: A Scientific Statement From the American Heart Association
Circulation: Cardiovascular Quality and Outcomes, Dec. 11, 2023

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Circulation, Oct. 9, 2023

Food Is Medicine: A Presidential Advisory From the American Heart Association
Circulation, Sep. 28, 2023

Kritchevsky Memorial Lecturer Cheryl A. M. Anderson, PhD, MPH, MS, FAHA

Colleen K. Spees, PhD, MEd, RDN, LD, FAND, FAHA interviews the 2024 David Kritchevsky Memorial Lecturer Cheryl A. M. Anderson, PhD, MPH, MS, FAHA about her talk, "Traveling the Last Mile: The Road to Sustainable Global Impact of Healthy Diets on Cardiovascular Health."

Using the PREVENT™ Calculator

Chiadi Ndumele, MD, PhD, MHS, chair of the AHA Presidential Advisory on Cardiovascular-Kidney-Metabolic Health, leads a frequently asked questions discussion with Sadiya S. Khan, MD, MSc, lead author for the American Heart Association scientific statement that introduced the novel prediction equations used to develop the PREVENT risk calculator to help clinicians better understand how to make the best use of this new tool.

Ideal Cardiovascular Health and Its Change with Cardiovascular-Kidney Outcomes in Young Adults

Alyssa M. Vela, PhD interviews Hokyou Lee, MD, PhD about work he presented on changes in ideal cardiovascular health and the impact on cardiovascular-kidney outcomes in young adults.

2024 Stamler Award Winner Wendy Wang, PhD

Laura J. Rasmussen-Torvik, MPH, PhD interview Wendy Wang, PhD about her Stamler award-winning study, "Association of SGLT2 Inhibitors and Other Second Line Therapies With Incident Chronic Kidney Disease in Patients With Type 2 Diabetes."